Molecular Autoimmunity

- Preface –Contributors –Innate Immunity in Experimental Autoimmune Myocarditis –Toll-Like Receptor 9 and Autoimmunity –C-Reactive Protein as a Regulator of Autoimmune Disease –NKT Cells and Autoimmune Type 1 Diabetes –The Genetics of Human Autoimmune Diseases –Failure to Maintain T cell DNA Methylation and Chromatin Structure Contributes to Human Lupus –Complement Components C4A and C4B in Human Lupus –Non-MHC Genetic Polymorphisms with Functional Importance for Human Myasthenia Gravis –Rheumatic Heart Disease: Molecular Basis of Autoimmune Reactions Leading to Valvular Lesions –Autoimmunity Against Desmogleins in Pemphigus Vulgaris –The Molecular Basis of Celiac Disease –Intrathymic Expression of Neuromuscular Acetylcholine Receptors and the Immunopathogenesis of Myasthenia Gravis –Autoantiboties and Nephritis: Different Roads May Lead to Rome –Estrogen, Interferon-gamma, and Lupus –Extent of Regulatory T cell Influence on Major Histocompatibility Complex Class II Gene Control of Susceptibility in Murine Autoimmune Thyroiditis –The Role of Autoimmunity in Multiple Sclerosis –Crippled B Lymphocyte Signaling Checkpoints in Systemic Autoimmunity –Disrupted T cell Receptor Signaling Pathways in Systemic Autoimmunity –Immune cell Signaling and Gene Transcription in Human Systemic Lupus Erythematosus –Accumulation of Self-Antigens in Systemic Lupus Erythematosus –B Lymphocyte Depletion Therapy in Autoimmune Disorders: Chasing Trojan Horse? –B Lymphocyte Stimulator (BLyS) and Autoimmune Rheumatic Diseases –Control and Induction of Autoimmunity by Cytokine and Anti-Cytokine Treatments –Hematopoietic Stem Cell Transplantation for the Treatment of Severe Autoimmune Diseases –Molecular Mimicry in Autoimmune Uveitis: From Pathogenesis to Therapy –Molecular Pathogenesis of the Antiphospholipid Syndrome: Towards Novel Therapeutic Targets –A Novel Approach to the Prevention of Atherosclerosis –Antigen-SpecificRegulation of Autoimmunity -Index